STELARA sol inj 45 mg/0.5ml flac

7680590660032 CH-59066 L04AC05 07.15.0.

Reimbursement limitations:

STELARACU2

Colite ulcéreuse
Traitement des patients adultes atteints de colite ulcéreuse active modérée à sévère chez …

STELARA sol inj 45 mg/0.5ml flac
STELARA sol inj 45 mg/0.5ml flac
STELARA sol inj 45 mg/0.5ml flac
1 / 3
google

Details

Product number
5906601
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
ustekinumabum 45 mg, saccharum, histidinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Articles (1)

Stelara 45 mg, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
15/04/2025
Professional SmPC
Français
15/04/2025
Professional SmPC
Italien
15/04/2025
Patient information leaflet
Allemand
02/09/2024
Patient information leaflet
Français
02/09/2024
Patient information leaflet
Italien
02/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
45.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 3360.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2017

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
59066
Drug name
Stelara, Injektionslösung
Galenic form
LSPA
ATC Code
L04AC05
Authorization status
Z
Dispensation category
B
First authorization
29/10/2010
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Plaque-Psoriasis ab 6 Jahren, Psoriasis-Arthritis bei Erwachsenen, Morbus Crohn bei Erwachsenen, Ulcerative colitis bei Erwachsenen

Packaging details

Description (FR)
STELARA sol inj 45 mg/0.5ml flac
Description (DE)
STELARA Inj Lös 45 mg/0.5ml Durchstf
Market launch
29/10/2010
Narcotic (BTM)
No

Other packaging sizes